Guangdong Jiaying Pharmaceutical Co Ltd (002198) - Total Assets

Latest as of September 2025: CN¥774.73 Million CNY ≈ $113.37 Million USD

Based on the latest financial reports, Guangdong Jiaying Pharmaceutical Co Ltd (002198) holds total assets worth CN¥774.73 Million CNY (≈ $113.37 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Guangdong Jiaying Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.

Guangdong Jiaying Pharmaceutical Co Ltd - Total Assets Trend (2004–2024)

This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data.

Guangdong Jiaying Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Guangdong Jiaying Pharmaceutical Co Ltd's total assets of CN¥774.73 Million consist of 66.0% current assets and 34.0% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	40.1%
Accounts Receivable	CN¥130.09 Million	15.5%
Inventory	CN¥85.06 Million	10.1%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥45.89 Million	5.5%
Goodwill	CN¥0.00	0.0%

Asset Composition Trend (2004–2024)

This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Guangdong Jiaying Pharmaceutical Co Ltd.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Guangdong Jiaying Pharmaceutical Co Ltd's current assets represent 66.0% of total assets in 2024, an increase from 25.1% in 2004.
Cash Position: Cash and equivalents constituted 40.1% of total assets in 2024, up from 3.3% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, a decrease from 8.0% in 2004.
Asset Diversification: The largest asset category is accounts receivable at 15.5% of total assets.

Guangdong Jiaying Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Guangdong Jiaying Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Novartis AG SW:NOVN	Switzerland	CHF115.49 Billion
AbbVie Inc NYSE:ABBV	USA	$133.96 Billion
Roche Holding AG SW:ROG	Switzerland	CHF100.70 Billion
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	China	CN¥17.48 Billion
AstraZeneca PLC LSE:AZN	UK	GBX114.07 Billion
Shandong Keyuan Pharmaceutical Co. Ltd. A SHE:301281	China	CN¥1.60 Billion
Korean Drug Co. Ltd KQ:014570	Korea	₩95.05 Billion
SANOFI CONS HEALTHC IND L NSE:SANOFICONR	India	Rs5.47 Billion

Guangdong Jiaying Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	15.15	25.41	4.80
Quick Ratio	12.38	21.14	4.00
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥435.34 Million	CN¥498.20 Million	CN¥344.06 Million

Guangdong Jiaying Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Guangdong Jiaying Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	5.64
Latest Market Cap to Assets Ratio	0.52
Asset Growth Rate (YoY)	-1.0%
Total Assets	CN¥838.82 Million
Market Capitalization	$433.71 Million USD

Valuation Analysis

Below Book Valuation: The market values Guangdong Jiaying Pharmaceutical Co Ltd's assets below their book value (0.52x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Guangdong Jiaying Pharmaceutical Co Ltd's assets decreased by 1.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2024)

The table below shows the annual total assets of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥838.82 Million ≈ $122.75 Million	-1.03%
2023-12-31	CN¥847.56 Million ≈ $124.03 Million	+0.11%
2022-12-31	CN¥846.65 Million ≈ $123.89 Million	+4.87%
2021-12-31	CN¥807.34 Million ≈ $118.14 Million	-0.14%
2020-12-31	CN¥808.44 Million ≈ $118.30 Million	-5.55%
2019-12-31	CN¥855.94 Million ≈ $125.25 Million	-3.78%
2018-12-31	CN¥889.56 Million ≈ $130.17 Million	+1.48%
2017-12-31	CN¥876.61 Million ≈ $128.28 Million	-20.25%
2016-12-31	CN¥1.10 Billion ≈ $160.86 Million	+4.89%
2015-12-31	CN¥1.05 Billion ≈ $153.35 Million	+1.23%
2014-12-31	CN¥1.04 Billion ≈ $151.49 Million	+12.65%
2013-12-31	CN¥919.00 Million ≈ $134.48 Million	+192.45%
2012-12-31	CN¥314.25 Million ≈ $45.98 Million	+2.51%
2011-12-31	CN¥306.55 Million ≈ $44.86 Million	+1.89%
2010-12-31	CN¥300.87 Million ≈ $44.03 Million	+18.77%
2009-12-31	CN¥253.33 Million ≈ $37.07 Million	+7.69%
2008-12-31	CN¥235.24 Million ≈ $34.42 Million	-4.17%
2007-12-31	CN¥245.48 Million ≈ $35.92 Million	+104.48%
2006-12-31	CN¥120.05 Million ≈ $17.57 Million	+31.59%
2005-12-31	CN¥91.23 Million ≈ $13.35 Million	+26.85%
2004-12-31	CN¥71.92 Million ≈ $10.52 Million	--

About Guangdong Jiaying Pharmaceutical Co Ltd

SHE:002198 China Drug Manufacturers - General

Market Cap

$433.71 Million

CN¥2.96 Billion CNY

Market Cap Rank

#13301 Global

#4192 in China

Share Price

CN¥5.84

Change (1 day)

+0.00%

52-Week Range

CN¥5.84 - CN¥8.43

All Time High

CN¥14.97